Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas.

Hdl Handle:
Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas.
Chanock, Stephen J; Burdett, Laurie; Yeager, Meredith; Llaca, Victor; Langerød, Anita; Presswalla, Shafaq; Kaaresen, Rolf; Strausberg, Robert L; Gerhard, Daniela S; Kristensen, Vessela; Perou, Charles M; Børresen-Dale, Anne-Lise
Breast cancer research : BCR 2007, 9 (1):R5

Full metadata record

DC FieldValue Language
dc.contributor.authorChanock, Stephen J-
dc.contributor.authorBurdett, Laurie-
dc.contributor.authorYeager, Meredith-
dc.contributor.authorLlaca, Victor-
dc.contributor.authorLangerød, Anita-
dc.contributor.authorPresswalla, Shafaq-
dc.contributor.authorKaaresen, Rolf-
dc.contributor.authorStrausberg, Robert L-
dc.contributor.authorGerhard, Daniela S-
dc.contributor.authorKristensen, Vessela-
dc.contributor.authorPerou, Charles M-
dc.contributor.authorBørresen-Dale, Anne-Lise-
dc.identifier.citationBreast cancer research : BCR 2007, 9 (1):R5en
dc.description.abstractINTRODUCTION: Genomic alterations have been observed in breast carcinomas that affect the capacity of cells to regulate proliferation, signaling, and metastasis. Re-sequence studies have investigated candidate genes based on prior genetic observations (changes in copy number or regions of genetic instability) or other laboratory observations and have defined critical somatic mutations in genes such as TP53 and PIK3CA. METHODS: We have extended the paradigm and analyzed 21 genes primarily identified by expression profiling studies, which are useful for breast cancer subtyping and prognosis. This study conducted a bidirectional re-sequence analysis of all exons and 5', 3', and evolutionarily conserved regions (spanning more than 16 megabases) in 91 breast tumor samples. RESULTS: Eighty-seven unique somatic alterations were identified in 16 genes. Seventy-eight were single base pair alterations, of which 23 were missense mutations; 55 were distributed across conserved intronic regions or the 5' and 3' regions. There were nine insertion/deletions. Because there is no a priori way to predict whether any one of the identified synonymous and noncoding somatic alterations disrupt function, analysis unique to each gene will be required to establish whether it is a tumor suppressor gene or whether there is no effect. In five genes, no somatic alterations were observed. CONCLUSION: The study confirms the value of re-sequence analysis in cancer gene discovery and underscores the importance of characterizing somatic alterations across genes that are related not only by function, or functional pathways, but also based upon expression patterns.en
dc.subjectVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Onkologi: 762en
dc.subject.meshBreast Neoplasmsen
dc.subject.meshConserved Sequenceen
dc.subject.meshDNA Mutational Analysisen
dc.subject.meshGene Expression Profilingen
dc.titleSomatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas.en
dc.typeJournal articleen
dc.typepeer revieweden
dc.contributor.departmentSection of Genomic Variation, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-4605, USA. chanocks@mail.nih.goven
dc.contributor.departmentUllevaal University Hospitalen
dc.identifier.journalBreast cancer research : BCRen
All Items in HeRA are protected by copyright, with all rights reserved, unless otherwise indicated.